Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Curr Ophthalmol Rep. 2017 Feb 2;5(1):38–48. doi: 10.1007/s40135-017-0119-2

Table 1.

Stepwise management of High-risk keratoplasty

1. Potent and frequent topical steroids -- continued indefinitely on a tapering dose
2. Topical tacrolimus (or CsA) as adjunctive therapy -- continued indefinitely
3. Systemic steroids peri-operatively
4. Systemic mycophenolate (azathioprine or rapamycin alternative)
5. Systemic tacrolimus (or cyclosporine) in addition to mycophenolate